Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
North America is the largest consumption place, with a consumption market share nearly 60.9% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 21.3%, China and Japan are also an important sales region for the peptide therapeutics.
Market Analysis and Insights: Global Peptide Therapeutics Market
In 2019, the global Peptide Therapeutics market size was US$ 31680 million and it is expected to reach US$ 42390 million by the end of 2026, with a CAGR of 4.2% during 2021-2026.
Global Peptide Therapeutics Scope and Market Size
Peptide Therapeutics market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Peptide Therapeutics market is segmented into
Injection
Oral
Other
The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Segment by Application, the Peptide Therapeutics market is segmented into
Cancer
Metabolic Disorders
Central Nervous System
Other
The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Peptide Therapeutics market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Peptide Therapeutics product introduction, recent developments, Peptide Therapeutics sales by region, type, application and by sales channel.
The major companies include:
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
J & J
The Medicines
North America is the largest consumption place, with a consumption market share nearly 60.9% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 21.3%, China and Japan are also an important sales region for the peptide therapeutics.
Market Analysis and Insights: Global Peptide Therapeutics Market
In 2019, the global Peptide Therapeutics market size was US$ 31680 million and it is expected to reach US$ 42390 million by the end of 2026, with a CAGR of 4.2% during 2021-2026.
Global Peptide Therapeutics Scope and Market Size
Peptide Therapeutics market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Peptide Therapeutics market is segmented into
Injection
Oral
Other
The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Segment by Application, the Peptide Therapeutics market is segmented into
Cancer
Metabolic Disorders
Central Nervous System
Other
The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Peptide Therapeutics Market Share AnalysisPeptide Therapeutics market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Peptide Therapeutics product introduction, recent developments, Peptide Therapeutics sales by region, type, application and by sales channel.
The major companies include:
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
J & J
The Medicines
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
